These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 38274668)

  • 21. The long winding road to the safer glucocorticoid receptor (GR) targeting therapies.
    Lesovaya EA; Chudakova D; Baida G; Zhidkova EM; Kirsanov KI; Yakubovskaya MG; Budunova IV
    Oncotarget; 2022; 13():408-424. PubMed ID: 35198100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Current insights into the development of new glucocorticoid receptor ligands].
    Buttgereit F; Song IH; Straub RH; Burmester GR
    Z Rheumatol; 2005 Apr; 64(3):170-6. PubMed ID: 15868334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-induced ocular disorders.
    Li J; Tripathi RC; Tripathi BJ
    Drug Saf; 2008; 31(2):127-41. PubMed ID: 18217789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice.
    Kleiman A; Tuckermann JP
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):98-108. PubMed ID: 17587493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity.
    Belvisi MG; Wicks SL; Battram CH; Bottoms SE; Redford JE; Woodman P; Brown TJ; Webber SE; Foster ML
    J Immunol; 2001 Feb; 166(3):1975-82. PubMed ID: 11160246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
    Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS
    Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. JTP-117968, a novel selective glucocorticoid receptor modulator, exhibits significant anti-inflammatory effect while maintaining bone mineral density in mice.
    Kurimoto T; Tamai I; Nakagawa T; Miyai A; Yamamoto Y; Kosugi Y; Deai K; Hata T; Ohta T; Matsushita M; Yamada T
    Eur J Pharmacol; 2021 Mar; 895():173880. PubMed ID: 33476654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JTP-117968, a novel selective glucocorticoid receptor modulator, exhibits improved transrepression/transactivation dissociation.
    Kurimoto T; Tamai I; Miyai A; Kosugi Y; Nakagawa T; Yamamoto Y; Deai K; Misaki S; Bessho Y; Negoro T; Yamaguchi T; Hata T; Matsushita M
    Eur J Pharmacol; 2017 May; 803():179-186. PubMed ID: 28366807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells.
    Clark AF; Wilson K; McCartney MD; Miggans ST; Kunkle M; Howe W
    Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):281-94. PubMed ID: 8300356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor β2 (TGFβ2) signaling plays a key role in glucocorticoid-induced ocular hypertension.
    Kasetti RB; Maddineni P; Patel PD; Searby C; Sheffield VC; Zode GS
    J Biol Chem; 2018 Jun; 293(25):9854-9868. PubMed ID: 29743238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small RNA Sequencing Reveals a Distinct MicroRNA Signature between Glucocorticoid Responder and Glucocorticoid Non-Responder Primary Human Trabecular Meshwork Cells after Dexamethasone Treatment.
    Kathirvel K; Fan X; Haribalaganesh R; Bharanidharan D; Sharmila R; Krishnadas R; Muthukkaruppan V; Willoughby CE; Senthilkumari S
    Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic lupus erythematosus and ocular involvement: an overview.
    Dammacco R
    Clin Exp Med; 2018 May; 18(2):135-149. PubMed ID: 29243035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The glucocorticoid receptor in inflammatory processes: transrepression is not enough.
    Hübner S; Dejager L; Libert C; Tuckermann JP
    Biol Chem; 2015 Nov; 396(11):1223-31. PubMed ID: 25910399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-inflammatory actions of glucocorticoids: molecular mechanisms.
    Barnes PJ
    Clin Sci (Lond); 1998 Jun; 94(6):557-72. PubMed ID: 9854452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic and nongenomic effects of glucocorticoids.
    Stahn C; Buttgereit F
    Nat Clin Pract Rheumatol; 2008 Oct; 4(10):525-33. PubMed ID: 18762788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist.
    Baiula M; Spartà A; Bedini A; Carbonari G; Bucolo C; Ward KW; Zhang JZ; Govoni P; Spampinato S
    Mol Vis; 2011; 17():3208-23. PubMed ID: 22194647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of tocilizumab in autoimmune eye diseases.
    Atienza-Mateo B; Prieto-Peña D; Vicente-Rabaneda EF; Blanco R; González-Gay MA; Castañeda S
    Expert Opin Biol Ther; 2022 Jun; 22(6):789-799. PubMed ID: 35422184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical features of glucocorticoid eye drops induced ocular hypertension in pediatric and adult uveitic eyes].
    Pei MH; Zhao C; Gao F; Zhang MF
    Zhonghua Yan Ke Za Zhi; 2018 Nov; 54(11):839-842. PubMed ID: 30440155
    [No Abstract]   [Full Text] [Related]  

  • 39. Development of novel treatment strategies for inflammatory diseases-similarities and divergence between glucocorticoids and GILZ.
    Cheng Q; Morand E; Yang YH
    Front Pharmacol; 2014; 5():169. PubMed ID: 25100999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The glucocorticoid receptor agonistic modulators CpdX and CpdX-D3 do not generate the debilitating effects of synthetic glucocorticoids.
    Hua G; Zein N; Paulen L; Chambon P
    Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14200-14209. PubMed ID: 31221758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.